{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T06:32:21Z","timestamp":1792305141636,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7568","license":[{"start":{"date-parts":[[2015,9,9]],"date-time":"2015-09-09T00:00:00Z","timestamp":1441756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,9,9]],"date-time":"2015-09-09T00:00:00Z","timestamp":1441756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2015,9,10]]},"DOI":"10.1038\/nature15369","type":"journal-article","created":{"date-parts":[[2015,9,8]],"date-time":"2015-09-08T10:42:19Z","timestamp":1441708939000},"page":"247-250","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":483,"title":["Evidence for human transmission of amyloid-\u03b2 pathology and cerebral amyloid angiopathy"],"prefix":"10.1038","volume":"525","author":[{"given":"Zane","family":"Jaunmuktane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Mead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D. F.","family":"Wadsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Nicoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Kenny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Launchbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Linehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Richard-Loendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Sarah","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rudge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Collinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Brandner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,9]]},"reference":[{"key":"BFnature15369_CR1","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1212\/01.WNL.0000084000.27403.15","volume":"61","author":"AJ Swerdlow","year":"2003","unstructured":"Swerdlow, A. J., Higgins, C. D., Adlard, P., Jones, M. E. & Preece, M. A. Creutzfeldt-Jakob disease in United Kingdom patients treated with human pituitary growth hormone. Neurology 61, 783\u2013791 (2003)","journal-title":"Neurology"},{"key":"BFnature15369_CR2","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3201\/eid1806.120116","volume":"18","author":"P Brown","year":"2012","unstructured":"Brown, P. et al. Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg. Infect. Dis. 18, 901\u2013907 (2012)","journal-title":"Emerg. Infect. Dis."},{"key":"BFnature15369_CR3","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/ana.410300503","volume":"30","author":"JP Vonsattel","year":"1991","unstructured":"Vonsattel, J. P. et al. Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann. Neurol. 30, 637\u2013649 (1991)","journal-title":"Ann. Neurol."},{"key":"BFnature15369_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.neurobiolaging.2013.07.017","volume":"35","author":"J Beck","year":"2014","unstructured":"Beck, J. et al. Validation of next-generation sequencing technologies in genetic diagnosis of dementia. Neurobiol. Aging 35, 261\u2013265 (2014)","journal-title":"Neurobiol. Aging"},{"key":"BFnature15369_CR5","doi-asserted-by":"publisher","unstructured":"Rudge, P. et al. Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years. Brain. http:\/\/dx.doi.org\/10.1093\/brain\/awv235 (2015)","DOI":"10.1093\/brain\/awv235"},{"key":"BFnature15369_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/BF02778005","volume":"8","author":"HF Baker","year":"1994","unstructured":"Baker, H. F., Ridley, R. M., Duchen, L. W., Crow, T. J. & Bruton, C. J. Induction of beta (A4)-amyloid in primates by injection of Alzheimer\u2019s disease brain homogenate. Comparison with transmission of spongiform encephalopathy. Mol. Neurobiol. 8, 25\u201339 (1994)","journal-title":"Mol. Neurobiol."},{"key":"BFnature15369_CR7","doi-asserted-by":"publisher","first-page":"12926","DOI":"10.1073\/pnas.0903200106","volume":"106","author":"YS Eisele","year":"2009","unstructured":"Eisele, Y. S. et al. Induction of cerebral \u03b2-amyloidosis: intracerebral versus systemic A\u03b2 inoculation. Proc. Natl Acad. Sci. USA 106, 12926\u201312931 (2009)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature15369_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00401-011-0912-1","volume":"123","author":"T Hamaguchi","year":"2012","unstructured":"Hamaguchi, T. et al. The presence of A\u03b2 seeds, and not age per se, is critical to the initiation of A\u03b2 deposition in the brain. Acta Neuropathol. 123, 31\u201337 (2012)","journal-title":"Acta Neuropathol."},{"key":"BFnature15369_CR9","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/embor.2013.137","volume":"14","author":"G Heilbronner","year":"2013","unstructured":"Heilbronner, G. et al. Seeded strain-like transmission of \u03b2-amyloid morphotypes in APP transgenic mice. EMBO Rep. 14, 1017\u20131022 (2013)","journal-title":"EMBO Rep."},{"key":"BFnature15369_CR10","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1126\/science.1131864","volume":"313","author":"M Meyer-Luehmann","year":"2006","unstructured":"Meyer-Luehmann, M. et al. Exogenous induction of cerebral \u03b2-amyloidogenesis is governed by agent and host. Science 313, 1781\u20131784 (2006)","journal-title":"Science"},{"key":"BFnature15369_CR11","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1126\/science.1194516","volume":"330","author":"YS Eisele","year":"2010","unstructured":"Eisele, Y. S. et al. Peripherally applied A\u03b2-containing inoculates induce cerebral \u03b2-amyloidosis. Science 330, 980\u2013982 (2010)","journal-title":"Science"},{"key":"BFnature15369_CR12","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1146\/annurev.neuro.24.1.519","volume":"24","author":"J Collinge","year":"2001","unstructured":"Collinge, J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev. Neurosci. 24, 519\u2013550 (2001)","journal-title":"Annu Rev. Neurosci."},{"key":"BFnature15369_CR13","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1016\/S0140-6736(06)68930-7","volume":"367","author":"J Collinge","year":"2006","unstructured":"Collinge, J. et al. Kuru in the 21st century\u2014an acquired human prion disease with very long incubation periods. Lancet 367, 2068\u20132074 (2006)","journal-title":"Lancet"},{"key":"BFnature15369_CR14","doi-asserted-by":"publisher","first-page":"E1666","DOI":"10.1210\/jc.2011-1357","volume":"96","author":"JY Abrams","year":"2011","unstructured":"Abrams, J. Y. et al. Lower risk of Creutzfeldt-Jakob disease in pituitary growth hormone recipients initiating treatment after 1977. J. Clin. Endocrinol. Metab. 96, E1666\u2013E1669 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnature15369_CR15","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1098\/rstb.2008.0091","volume":"363","author":"S Brandner","year":"2008","unstructured":"Brandner, S. et al. Central and peripheral pathology of kuru: pathological analysis of a recent case and comparison with other forms of human prion disease. Phil. Trans. R. Soc. Lond. B 363, 3755\u20133763 (2008)","journal-title":"Phil. Trans. R. Soc. Lond. B"},{"key":"BFnature15369_CR16","volume-title":"Neuropathology: A reference Text of CNS Pathology","author":"D Ellison","year":"2012","unstructured":"Ellison, D. et al. Neuropathology: A reference Text of CNS Pathology. 3rd edn (Elsevier, 2012)"},{"key":"BFnature15369_CR17","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00401-012-1002-8","volume":"124","author":"P Parchi","year":"2012","unstructured":"Parchi, P. et al. Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA. Acta Neuropathol. 124, 517\u2013529 (2012)","journal-title":"Acta Neuropathol."},{"key":"BFnature15369_CR18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","volume":"18","author":"H Braak","year":"1997","unstructured":"Braak, H. & Braak, E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging 18, 351\u2013357 (1997)","journal-title":"Neurobiol. Aging"},{"key":"BFnature15369_CR19","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s004010050870","volume":"96","author":"JA Hainfellner","year":"1998","unstructured":"Hainfellner, J. A. et al. Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease. Acta Neuropathol. 96, 116\u2013122 (1998)","journal-title":"Acta Neuropathol."},{"key":"BFnature15369_CR20","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1001\/jamaneurol.2013.1933","volume":"70","author":"DJ Irwin","year":"2013","unstructured":"Irwin, D. J. et al. Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone. JAMA Neurol. 70, 462\u2013468 (2013)","journal-title":"JAMA Neurol."},{"key":"BFnature15369_CR21","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1126\/science.1138718","volume":"318","author":"J Collinge","year":"2007","unstructured":"Collinge, J. & Clarke, A. R. A general model of prion strains and their pathogenicity. Science 318, 930\u2013936 (2007)","journal-title":"Science"},{"key":"BFnature15369_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0165-5728(88)90140-3","volume":"20","author":"DC Gajdusek","year":"1988","unstructured":"Gajdusek, D. C. Transmissible and non-transmissible amyloidoses: autocatalytic post-translational conversion of host precursor proteins to beta-pleated sheet configurations. J. Neuroimmunol. 20, 95\u2013110 (1988)","journal-title":"J. Neuroimmunol."},{"key":"BFnature15369_CR23","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00401-013-1231-5","volume":"127","author":"F Clavaguera","year":"2014","unstructured":"Clavaguera, F. et al. Peripheral administration of tau aggregates triggers intracerebral tauopathy in transgenic mice. Acta Neuropathol. 127, 299\u2013301 (2014)","journal-title":"Acta Neuropathol."},{"key":"BFnature15369_CR24","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00401-014-1324-9","volume":"128","author":"M Beekes","year":"2014","unstructured":"Beekes, M., Thomzig, A., Schulz-Schaeffer, W. J. & Burger, R. Is there a risk of prion-like disease transmission by Alzheimer- or Parkinson-associated protein particles? Acta Neuropathol. 128, 463\u2013476 (2014)","journal-title":"Acta Neuropathol."},{"key":"BFnature15369_CR25","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.2353\/ajpath.2007.070403","volume":"171","author":"T Bolmont","year":"2007","unstructured":"Bolmont, T. et al. Induction of tau pathology by intracerebral infusion of amyloid-\u03b2-containing brain extract and by amyloid-beta deposition in APP \u00d7 Tau transgenic mice. Am. J. Pathol. 171, 2012\u20132020 (2007)","journal-title":"Am. J. Pathol."},{"key":"BFnature15369_CR26","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1136\/jnnp.2005.070805","volume":"77","author":"M Preusser","year":"2006","unstructured":"Preusser, M. et al. Alzheimer-type neuropathology in a 28 year old patient with iatrogenic Creutzfeldt-Jakob disease after dural grafting. J. Neurol. Neurosurg. Psychiatry 77, 413\u2013416 (2006)","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnature15369_CR27","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S1474-4422(08)70001-2","volume":"7","author":"CC Rowe","year":"2008","unstructured":"Rowe, C. C. et al. Imaging of amyloid beta in Alzheimer\u2019s disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism. Lancet Neurol. 7, 129\u2013135 (2008)","journal-title":"Lancet Neurol."},{"key":"BFnature15369_CR28","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1001\/archneurol.2011.100","volume":"68","author":"ML Daviglus","year":"2011","unstructured":"Daviglus, M. L. et al. Risk factors and preventive interventions for Alzheimer disease: state of the science. Arch. Neurol. 68, 1185\u20131190 (2011)","journal-title":"Arch. Neurol."},{"key":"BFnature15369_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000109675","volume":"16","author":"ES O\u2019Meara","year":"1997","unstructured":"O\u2019Meara, E. S. et al. Alzheimer\u2019s disease and history of blood transfusion by apolipoprotein-E genotype. Neuroepidemiology 16, 86\u201393 (1997)","journal-title":"Neuroepidemiology"},{"key":"BFnature15369_CR30","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00401-014-1339-2","volume":"128","author":"SK Fritschi","year":"2014","unstructured":"Fritschi, S. K. et al. A\u03b2 seeds resist inactivation by formaldehyde. Acta Neuropathol. 128, 477\u2013484 (2014)","journal-title":"Acta Neuropathol."},{"key":"BFnature15369_CR31","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.neurobiolaging.2013.07.017","volume":"35","author":"J Beck","year":"2014","unstructured":"Beck, J. et al. Validation of next-generation sequencing technologies in genetic diagnosis of dementia. Neurobiol. Aging 35, 261\u2013265 (2014)","journal-title":"Neurobiol. Aging"},{"key":"BFnature15369_CR32","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/j.1365-2990.2008.00963.x","volume":"34","author":"AM Isaacs","year":"2008","unstructured":"Isaacs, A. M. et al. Lack of TAR-DNA binding protein-43 (TDP-43) pathology in human prion diseases. Neuropathol. Appl. Neurobiol. 34, 446\u2013456 (2008)","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"BFnature15369_CR33","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1099\/vir.0.80375-0","volume":"86","author":"A Khalili-Shirazi","year":"2005","unstructured":"Khalili-Shirazi, A. et al. PrP glycoforms are associated in a strain-specific ratio in native PrPSc. J. Gen. Virol. 86, 2635\u20132644 (2005)","journal-title":"J. Gen. Virol."},{"key":"BFnature15369_CR34","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-1-59745-234-2_14","volume":"459","author":"JD Wadsworth","year":"2008","unstructured":"Wadsworth, J. D. et al. Molecular diagnosis of human prion disease. Methods Mol. Biol. 459, 197\u2013227 (2008)","journal-title":"Methods Mol. Biol."},{"key":"BFnature15369_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman, B. T. et al. National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers Dement. 8, 1\u201313 (2012)","journal-title":"Alzheimers Dement."},{"key":"BFnature15369_CR36","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal, D. R., R\u00fcb, U., Orantes, M. & Braak, H. Phases of A\u03b2-deposition in the human brain and its relevance for the development of AD. Neurology 58, 1791\u20131800 (2002)","journal-title":"Neurology"},{"key":"BFnature15369_CR37","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H. & Del Tredici, K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 112, 389\u2013404 (2006)","journal-title":"Acta Neuropathol."},{"key":"BFnature15369_CR38","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra, S. S. et al. The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41, 479\u2013486 (1991)","journal-title":"Neurology"},{"key":"BFnature15369_CR39","first-page":"415","volume":"2","author":"A Heyman","year":"1990","unstructured":"Heyman, A., Fillenbaum, G. G. & Mirra, S. S. Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD): clinical, neuropsychological, and neuropathological components. Aging (Milano) 2, 415\u2013424 (1990)","journal-title":"Aging (Milano)"},{"key":"BFnature15369_CR40","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/(SICI)1097-0320(20000401)39:4<275::AID-CYTO5>3.0.CO;2-8","volume":"39","author":"JA van Der Laak","year":"2000","unstructured":"van Der Laak, J. A., Pahlplatz, M. M., Hanselaar, A. G. & de Wilde, P. C. Hue-saturation-density (HSD) model for stain recognition in digital images from transmitted light microscopy. Cytometry 39, 275\u2013284 (2000)","journal-title":"Cytometry"}],"updated-by":[{"DOI":"10.1038\/nature15704","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T00:00:00Z","timestamp":1442361600000}}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature15369.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature15369","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature15369.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:45:39Z","timestamp":1684417539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature15369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,9]]},"references-count":40,"journal-issue":{"issue":"7568","published-print":{"date-parts":[[2015,9,10]]}},"alternative-id":["BFnature15369"],"URL":"https:\/\/doi.org\/10.1038\/nature15369","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725776809.793510254","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.725776809.793539399","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,9]]},"assertion":[{"value":"26 April 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2015","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Due to an administrative error, an incorrect version of the Competing Financial Interests (CFI) statement was published in relation to this paper. Although the published CFI statement did reference the authors' affiliation with D-Gen, it did not contain all of the information provided to <i>Nature<\/i> by the authors about the interests of the company. As soon as <i>Nature<\/i> was made aware of the error, we acted quickly to correct the text and expand the CFI statement. The CFI statement for this paper as originally published was \"J.C. is a Director and J.C. and J.D.F.W. are shareholders of D-Gen Limited, which supplies antibody ICSM35.\"  The updated CFI statement is \u201cJ.C. is a Director and J.C. and J.D.F.W. are shareholders of D-Gen Limited, an academic spin-out company working in the field of prion disease diagnosis, decontamination and therapeutics. D-Gen supplied antibody ICSM35\u201d.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.C. is a Director and J.C. and J.D.F.W. are shareholders of D-Gen Limited, an academic spin-out company working in the field of prion disease diagnosis, decontamination and therapeutics. D-Gen supplied antibody ICSM35.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}